Neurotoxic brainstem impairment as proposed threshold event in autistic regression

Autism: Oxidative Stress, Inflammation, and Immune Abnormalities

Volumn , Issue , 2009, Pages 153-176

  McGinnis, Woody R ^a   Miller, Veronica M ^b   Audhya, Tapan ^c,d   Edelson, Stephen M ^e  

^a Autism House   (New Zealand)

^b WADSWORTH CENTER   (United States)

^c Vitamin Diagnostics Laboratory   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Autism Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902987906     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (159)

1. Adams, J.B., Romdalvik, J., Ramanujam, V.M., and Legator, M.S. 2007. Mercury, lead, and zinc in baby teeth of children with autism versus controls. J. Toxicol. Environ. Health A. 70:1046-1051.
2. Afzal, N., Murch, S., Thirrupathy, K., Berger, L., Fagbemi, A., and Heuschkel, R. 2003. Constipation with acquired megarectum in children with autism. Pediatrics 112:939-942.
3. Agnati, L.F., Zoli, M., Stromberg, I., and Fuxe, K. 1995. Intercellular communication in the brain: Wiring versus volume transmission. Neuroscience 69:711-726.
4. Allegra, M., Reiter, R.J., Tan, D.X., Gentile, C., Tesoriere, L., and Livrea, M.A. 2003. The chemistry of melatonin’s interaction with reactive species. J. Pineal Res. 34:1-10.
5. Althaus, M., Van Roon, S.M., Lambertus, Mulder, L.J.M., Mulder, G., Aarnoudse, C.C., and Minderaa, R.B. (2004). Autonomic response patterns observed during the performance of an attention-demanding task in two groups of children with autistic-type difficulties in social adjustment. Psychophysiology 41:893-904.
6. Ammori, J.B., Zhang, W.Z., Li, J.Y., Chai, B.X., and Mulholland, M.W. 2008. Effect of intestinal inflammation on neuronal survival and function in the dorsal motor nucleus of the vagus. Surgery 144:149-158.
7. Arvidson, B. 1986. Autoradiographic localization of cadmium in the rat brain. Neurotoxicology 7:89-96.
8. Arvidson, B. 1992. Accumulation of inorganic mercury in lower motoneurons of mice. Neurotoxicology 13:277-80.
9. Arvidson, B. and Tjalve, H. 1986. Distribution of 109Cd in the nervous system of rats after intravenous injection. Acta Neuropathol. 69:111-116.
10. Bailey, A., Luthert, P., Dean, A., Harding, B., Janota, I., Montgomery, M., Rutter, M., and Lantos, P. 1998. A clinicopathological study of autism. Brain 121:889-905.
11. Bandyopadhyay, D., Biswas, K., Bhattacharyya, M., Reiter, R.J., and Banerjee, R.K. 2002. Involvement of reactive oxygen species in gastric ulceration: Protection by melatonin. Indian J. Exp. Biol. 2002:693-705.
12. Banks, W.A. 2000. Protector, prey and perpetrator: The pathophysiology of the blood-brain barrier in neuroAIDS. NeuroAIDS 3:1-5.
13. Bassotti, G., Germani, U., Pagliaricci, S., Plesa, A., Giulietti, O., Mannarino, E., and Morelli, A. 1998. Esophageal manometric abnormalities in Parkinson’s disease. Dysphagia 13:28-31.
14. Basu, N., Scheuhammer, A.M., Sonne, C., Letcher, R.J., Born, E.W., and Dietz, R. 2009. Is dietary mercury of toxicological concern to wild polar bears (Ursus maritimus)? Environ. Toxicol. Chem. 28:133-140.
15. Bauman, M. and Kemper, T.L. 1985. Histoanatomic observations of the brain in early infantile autism. Neurology 35:866-874.
16. Bawari, M., Babu, G.N., Ali, M.M., and Misra, U.K. 1995. Effect of neonatal monosodium glutamate on lipid peroxidation in adult rat brain. Neuroreport 6:650-652.
17. Baydas, G., Nedzvetsky, V.S., Nerush, P.A., Krichenko, S.V., Demchenko, H.M., and Reiter, R.J. 2002. A novel role for melatonin: Regulation of the expression of cell adhesion molecules in the rat hippocampus and cortex. Neurosci. Lett. 326:109-112.
18. Bernard, S., Enayati, A., Redwood, L., Roger, H., and Binstock, T. 2001. Autism: A novel form of mercury poisoning. Med. Hypotheses 56:462-471.
19. Bonvallet, M. and Allen, M.B. 1963. Prolonged spontaneous and evoked reticular activation following discreet bulbar lesions. Electroencephal. Clin. Neurophysiol. 15:969-988.
20. Braak, H., Ghebremedhin, E., Rub, U., Bratzke, H., and Del Tredici, K., 2004. Stages in the development of Parkinson’s related pathology. Cell. Tissue Res. 31:121-134.
21. Breder, C.D., Hazuka, C., Ghayur, T., Klug, C., Huginin, M., Yasuda, K., Teng, M., and Saper, C.B. 1994. Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. Proc. Natl. Acad. Sci. U.S.A. 91:11393-11397.
22. Broadwell, R.D., Balin, B.J., Salcman, M., and Kaplan, R.S. 1983. Brain-blood barrier? Yes and no. Proc. Natl. Acad. Sci. U.S.A. 80:7352-7356.
23. Carter, C.S., Williams, J.R., Witt, D.M., and Insel, T.R. 1992. Oxytocin and social bonding. Ann. N.Y. Acad. Sci. 652:204-211.
24. Cersosimo, M.G. and Benarroch, E.E. 2008. Neural control of the gastrointestinal tract: Implications for Parkinson disease. Mov. Disord. 23:1065-1075.
25. Chaparro-Huerta, V., Rivera-Cervantes, M.C., Torres-Mendoza, B.M., and Beas-Zarate, C. 2002. Neuronal death and tumor necrosis factor-alpha response to glutamate-induced excitotoxicity in the cerebral cortex of neonatal rats. Neurosci. Lett. 333:95-98.
26. Charleston, J.S., Bolender, R.P., Mottet, N.K., Body, R.L., Vahter, M.E., and Burbacher, T.M. 1994. Increases in the number of reactive glia in the visual cortex of Macaca fascicularis following subclinical long-term methylmercury exposure. Toxicol. Appl. Pharmacol. 129:196-206.
27. Chauhan, A. and Chauhan, V. 2006. Oxidative stress in autism. Pathophysiology 13:171-181.
28. Chauhan, A., Sheikh, A.M., and Chauhan, V. 2008. Increased copper-mediated oxidation of membrane phosphatidylethanolamine in autism. Am. J. Biochem. Biotechnol. (Special Issue on Autism Spectrum Disorders) 4:101-104.
29. Chen, W., Body, R.L., and Mottet, N.K. 1983. Biochemical and morphological studies of monkeys chronically exposed to methylmercury. J. Toxicol. Environ. Health 12:407-416.
30. Chez, M.G., Dowling, T., Patel, P.B., Khanna, P., and Kominsky, M. 2007. Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr. Neurol. 36:361-365.
31. Cordes, S.P. 2005. Molecular genetics of the early development of hindbrain serotonergic neurons. Clin. Genet. 68:487-494.
32. Courchesne, E. 1997. Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism. Curr. Opin. Neurobiol. 7:269-278.
33. Curtis, K.S., Verbalis, J.G., and Stricker, E.M. 1996. Area postrema lesions in rats appear to disrupt rapid feedback inhibition of fluid intake. Brain Res. 726:31-38.
34. Davidovitch, M., Glick, L., Holtzman, G., Tirosh, E., and Safir, M.P. 2000. Developmental regression in autism: Maternal perception. J Autism Dev. Disord. 30:113-119.
35. De Sarno, P. and Pope, R.S. 1998. Phosphoinositide hydrolysis activated by muscarinic or glutamatergic, but not adrenergic, receptors is impaired in ApoE-deficient mice and by hydrogen peroxide and peroxynitrite. Exp. Neurol. 152:123-128.
36. Dufault, R., LeBlanc, B., Schnoll, R., Cornett, C., Schweitzer, L., Wallinga, D., Hightower, J., Patrick, L., and Lukiw, W.J. (2009). Mercury from chlor-alkali plants: Measured concentrations in food product sugar. Environ. Health 8:2.
37. Edwards, G.L., White, B.D., He, B., Dean, R.G., and Martin, R.J. 1997. Elevated hypothalamic neuropeptide Y levels in rats with dorsomedial hindbrain lesions. Brain Res. 755:84-90.
38. Eletskii, I., Kulikov, O.V., and Tsibulevskii, A. 1984. Reactions of Paneth cells of the rat jejunum to section of the vagus nerves (ultrastructural analysis). Arkh. Anat. Gistol. Embriol. 86:73-79.
39. Erroi, A., Bianchi, M., and Ghezzi, P. 1992. The pneumotoxicant paraquat potentiates IL-1 and TNF production by human mononuclear cells. Agents Actions 36:66-69.
40. Evans, T.A., Siedlak, S.L., Lu, L., Fu, X., Wang, Z., McGinnis, W.R., Fakhoury, E., Castellani, R.J., Hazen, S.L., Walsh, W.J., Lewis, A.T., Salomon, R.G., Smith, M.A., Perry, G., and Zhu, X. 2008. The autistic phenotype exhibits a remarkably localized modification of brain protein by products of free radical-induced lipid oxidation. Am. J. Biochem. Biotechnol. (Special Issue on Autism Spectrum Disorders) 4:61-72.
41. Fatemi, S.H., Halt, A.R., Stary, J.M., Kanodia, R., Schulz, S.C., and Realmuto, G.R. 2002. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry 52:805-810.
42. Ferguson, J.N., Young, L.J., Hearn, E.F., Matzuk, M.M., Insel, T.R., and Winslow, J.T. 2000. Social amnesia in mice lacking the oxytocin gene. Nat. Genet. 25:284-288.
43. Gajewski, M., Laskowska-Bozek, H., Orlewski, P., Maslinski, S., and Ryzewski, J. 1988. Influence of lipid peroxidation and hydrogen peroxide on muscarinic cholinergic receptors and ATP level in rat myocytes and lymphocytes. Int. J. Tissue React. 10:281-290.
44. Geier, D.A. and Geier, M.R. 2007. A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders. J. Toxicol. Environ. Health A. 70:837-851.
45. Geier, D.A., Kern, J.K., Garver, C.R., Adams, J.B., Audhya, T., Nataf, R., and Geier, M.R. (2008). Biomarkers of environmental toxicity and susceptibility in autism. J. Neurol. Sci. 280:101-118.
46. Geva, R. and Feldman, R. 2008. A neurobiological model for the effects of early brainstem functioning on the development of behavior and emotion regulation in infants: Implications for prenatal and perinatal risk. J. Child Psychol. Psychiatry 49:1031-1041.
47. Gilberg, C. and Schaumann, H. 1983. Epilepsy presenting as infantile autism? Two case studies. Neuropediatrics 14:206-212.
48. Goldberg, E.A. 2004. The link between gastroenterology and autism. Gastroenterol. Nurs. 27:16-19.
49. Goldberg, W.A., Osann, K., Filipek, P.A., Laulhere, T., Jarvis, K., Modahl, C., Flodman, P., and Spence, M.A. 2003. Language and other regression: Assessment and timing. J. Autism Dev. Disord. 33:607-616.
50. Grandjean, P. and Landrigan, P.J. 2006. Developmental neurotoxicity of industrial chemicals. Lancet 368:2167-2178.
51. Grandjean, P., Murata, K., Budtz-Jorgensen, E., and Weihe, P. 2004. Cardiac autonomic activity in methylmercury neurotoxicity: 14-year follow-up of a Faroese birth cohort. J. Pediatr. 144:169-176.
52. Green, L., Fein, D., Modahl, C., Feinstein, C., Waterhouse, L., and Morris, M. 2001. Oxytocin and autistic disorder: Alterations in peptide forms. Biol. Psychiatry 50:609-613.
53. Gross, P.M., Wall, K.M., Pang, J.J., Shaver, S.W., and Wainman, D.S. 1990. Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius. Am. J. Physiol. 259:1131-1138.
54. Gupta, Y.K., Gupta, M., and Kohli, K. 2003. Neuroprotective role of melatonin in oxidative stress vulnerable brain. Indian J. Physiol. Pharmacol. 47:373-386.
55. Halbach, S., Vogt, S., Kohler, W., Felgenhauer, N., Weizl, G., Kremers, L., Silker, T., and Melchart, D. 2008. Blood and urine mercury levels in adult amalgam patients of a randomized controlled trial: Interaction of Hg species in erythrocytes. Environ. Res. 107:69-78.
56. Hansen, R.L., Ozonoff, S., Krakowiak, P., Angkustsiri, K., Jones, C., Deprey, L.J., Le, D.N., Croen, L.A., and Hertz-Picciotto, I. 2008. Regression in autism: Prevalence and associated factors in the CHARGE Study. Ambul. Pediatr. 8:25-31.
57. Hashimoto, T., Tayama, M., Miyazaki, M., Murakawa, K., Shimakawa, S., Yoneda, Y., and Kuroda, Y. 1993. Brainstem involvement in high functioning autistic children. Acta Neurol. Scand. 88:123-128.
58. Havarinasab, X., Bjorn, E., Nielsen, J.B., and Hultman, P. 2007. Mercury species in lymphoid and non-lymphoid tissues after exposure to methyl mercury: Correlation with autoimmune parameters during and after treatment in susceptible mice. Toxicol. Appl. Pharmacol. 221:21-28.
59. Hermann, G.E. and Rogers, R.C. 2008. TNFalpha: A trigger of autonomic dysfunction. Neuroscientist 14:53-67.
60. Hollander, E., Novotny, S., Hanratty, M., Yaffe, R., DeCaria, C.M., Aronowitz, B.R., and Mosovich, S. 2003. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger’s disorders. Neuropsychopharmacology 28:193-198.
61. Horvath, K., Papadimitriou, J.C., Rabsztyn, A., Drachenberg, C., and Tildon, J.T. 1999. Gastrointestinal abnormalities in children with autistic disorder. J. Pediatr. 135:559-563.
62. Horvath, K., Stefanatos, G., Sokolski, K.N., Wachtel, R., Nabors, L., and Tildon, J.T. 1998. Improved social and language skills after secretin administration in patients with autism spectrum disorders. J. Assoc. Acad. Minor. Phys. 9:9-15.
63. Hrdina, P.D., Peters, D.A., and Singhai, R.L. 1976. Effects of chronic exposure to cadmium, lead and mercury of brain biogenic amines in rat. Res. Commun. Chem. Pathol. Pharmacol. 15:483-493.
64. Insel, T.R. 1997. A neurobiological basis of social attachment. Am. J. Psychiatry 154:726-735.
65. Insel, T.R. and Hulihan, T.J. 1995. A gender-specific mechanism for pair bonding: Oxytocin and partner preference. Behav. Neurosci. 109:782-789.
66. Insel, T.R., O’Brien, D.J., and Leckman, J.F. 1999. Oxytocin, vasopressin, and autism: Is there a connection? Biol. Psychiatry 45:145-157.
67. Institute of Medicine (2004). Immunization safety review committee: Vaccines and Autism. Washington, DC. http:/www.iom.edu/report.asp?id=20155
68. Johnson, A.K. and Edwards, G.L. (1991). Central projections of osmotic and hypervolaemic signals in homeostatic thirst. In Thirst-Physiological and Psychological Aspects, eds. D.J. Ramsay and D.A. Booth. New York: Springer-Verlag, pp. 149-175.
69. Johnson, A.K. and Gross, P.M. 1993. Sensory circumventricular organs and brain homeostatic pathways. FASEB J. 7:678-686.
70. Jou, R.J., Minshew, N.J., Melhem, N.M., Keshavan, M.S., and Hardan, A.Y. 2008. Brainstem volumetric alterations in children with autism. Psychol. Med. 24:1-8.
71. Jyonouchi, H., Sun, S., and Le, H. 2001. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J. Neuroimmunol. 120:170-179.
72. Kanner, L. 1943. Autistic disturbances of affective contact. Nervous Child. 2:217-250.
73. Karcsu, S., Jancso, G., Kreutzberg, G.W., Toth, L., Kiraly, E., Bacsy, E., and Laszlo, F.A. 1985. A glutamate-sensitive neuronal system originating from the area postrema terminates in and transports acetylcholinesterase to the nucleus of the solitary tract. J. Neurocytol. 14:563-578.
74. Kemper, T.L. and Bauman, M.L. 1993. The contribution of neuropathological studies to the understanding of autism. Neurol. Clin. 11:175-187.
75. Kern, J.K. and Jones, A.M. 2006. Evidence of toxicity, oxidative stress, and neuronal insult in autism. J. Toxicol. Environ. Health 9:485-499.
76. Kim, S.J., Jeong, H.J., Myung, N.Y., Kim, M.C., Lee, J.H., So, H.S., Park, R.K., Kim, H.J., Um, J.Y., and Hong, S.H. 2008. The protective mechanism of antioxidants in cadmium-induced ototoxicity in vitro and in vivo. Environ. Health Perspect. 116:854-862.
77. Klin, A. 1993. Auditory brainstem responses in autism: Brainstem dysfunction or peripheral hearing loss? J. Autism Dev. Disord. 23:15-35.
78. Kotler, M., Rodriguez, C., Sainz, R.M., Antolin, I., and Mendendez-Pelaez, A. 1998. Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J. Pineal Res. 24:83-89.
79. Kulesza, R.J. and Mangunay, K. 2008. Morphological features of the medial superior olive in autism. Brain Res. 1200:132-137.
80. Kulman, G., Lissoni, P., Rovelli, F., Roselli, M.G., Brivio, F., and Sequeri, P. 2000. Evidence of pineal endocrine hypofunction in autistic children. Neurol. Endocrinol. Lett. 21:31-34.
81. Kwon, S., Kim, J., Choe, B.H., Ko, C., and Park, S. 2007. Electrophysiological assessment of central auditory processing by auditory brainstem responses in children with autism spectrum disorders. J. Korean Med. Sci. 22:656-659.
82. Larsen, P.J., Moller, M., and Mikkelsen, J.D. 1991. Efferent projections from the periventricular and medial parvicellular subnuclei of the hypothalamic paraventricular nucleus to circumventricular organs of the rat: A Phaseolus vulgaris-leucoagglutinin (PHA-L) tracing study. J. Comp. Neurol. 306:462-479.
83. Lathe, R. 2008. Environmental factors and limbic vulnerability in childhood autism. Am. J. Biochem. Biotechnol. (Special Issue on Autism Spectrum Disorders) 4:183-197.
84. Lawrence, C.B., Allan, S.M., and Rothwell, N.J. (1998). Interleukin-1beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur. J. Neurosci. 10:1188-1195.
85. Lopez-Hurtado, E. and Prieto, J.J. 2008.A microscopic study of language-related cortex in autism. Am. J. Biochem. Biotechnol. (Special Issue on Autism Spectrum Disorders) 4:121-129.
86. Lord, C., Schulman, C., and DiLavore, P. 2004. Regression and word loss in autistic spectrum disorders. J Child Psychol. Psychiatry 45:936-955.
87. Madsen, K.M. and Vestergaard, M. 2004. MMR vaccination and autism: What is the evidence for a causal association? Drug Safety 27:831-840.
88. Mangano, E.N. and Hayley, S. (2009). Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration. Neurobiol. Aging 30:1361-1378.
89. Marvel, F.A., Chen, C.C., Badr, N., Gaykema, R.P., and Goehler, L.E. 2004. Reversible inactivation of the dorsal vagal complex blocks lipopolysaccharide-induced social withdrawal and c-Fos expression in central autonomic nuclei. Brain Behav. Immun. 18:123-134.
90. McCoy, M.K., Martinez, T.N., Ruhn, K.A., Szymkowski, D.E., Smith, C.G., Botterman, B.R., Tansey, K.E., and Tansey, M.G. 2006. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson’s disease. J. Neurosci. 26:9365-9375.
91. McGinnis, W.R. 2001. Mercury and autistic gut disease. Environ Health Perspect. 109:A303-304.
92. McGinnis, W.R. 2004. Oxidative stress in autism. Altern. Ther. Health Med. 10:22-36.
93. McGinnis, W.R. 2007. Could oxidative stress from psychosocial stress affect neurodevelopment in autism? J Autism Dev. Disord. 37:993-994.
94. Meister, B., Ceccatelli, S., Hokfelt, T., Anden, N.E., Anden, M., and Theodorsson, E. 1989. Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: Effects of monosodium glutamate (MSG) lesions. Neurochem. Int. 76:343-368.
95. Mendez-Armenta, M., Villeda-Hernandez, J., Barroso-Moguel, R., Nava-Ruiz, C., Jimenez-Capdeville, M.E., and Rios, C. 2003. Brain regional lipid peroxidation and metallothionein levels of developing rats exposed to cadmium and dexamethasone. Toxicol. Lett. 144:151-157.
96. Ming, X., Brimacombe, M., Malek, J.H., Jani, N., and Wagner, G.C. 2008. Autism spectrum disorders and identified toxic land fills: Co-occurrence across states. Environ. Health Insights 2:55-59.
97. Ming, X., Julu, P.O.O., Brimacombe, M., Connor, S., and Daniels, M.L. 2005. Reduced cardiac parasympathetic activity in children with autism. Brain Dev. 27:509-516.
98. Modahl, C., Green, L., Fein, D., Morris, M., Waterhouse, L., Feinstein, C., and Levin, H. 1998. Plasma oxytocin levels in autistic children. Biol. Psychiatry 43:270-277.
99. 2) per os. Environ. Res. 1:29-43.
100. Moosmann, B. and Behl, C. 2002. Secretory peptide hormones are biochemical antioxidants: Structure-activity relationship. Mol. Pharmacol. 61:260-268.
101. Murphy, J.V., Wheless, J.W., and Schmoll, C.M. 2000. Left vagal nerve stimulation in six patients with hypothalamic hamartomas. Pediatr. Neurol. 23:167-168.
102. Nadeau, S. and Rivest, S. 1999. Regulation of the gene encoding tumor necrosis factor alpha (TNF-alpha) in the rat brain and pituitary in response in different models of systemic immune challenge. Neuropathol. Exp. Neurol. 58:61-77.
103. Naylor, J.L., Widdowson, P.S., Simpson, M.G., Farnworth, M., Ellis, M.K., and Lock, E.A. 1995. Further evidence that the bloodNNNNNNNNbrain barrier impedes paraquat entry into the brain. Hum. Exp. Toxicol. 14:587-594.
104. Nelson, K.B. and Bauman, M.L. 2003. Thimerosal and autism? Pediatrics 111:674-679.
105. Nemeroff, C.B., Mayberg, H.S., Krahl, S.E., McNamara, J., Frazer, A., Henry, T.R., George, M.S., Charney, D.S., and Brannan, S.K. 2006. VNS therapy in treatmentresistant depression: Clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 31:1345-1355.
106. Nir, I., Meir, D., Zilber, N., Knowlber, H., Hadjez, J., and Lerner, Y. 1995. Brief report: Circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. J Autism Dev. Disord. 25:641-654.
107. Nordberg, G.F. and Sereniu, F. 1969. Distribution of inorganic mercury in the guinea pig brain. Acta Pharmacol. Toxicol. 27:269-283.
108. Onyango, I.G. 2008. Mitochondrial dysfunction and oxidative stress in Parkinson’s disease. Neurochem. Res. 33:589-597.
109. Opitz, H., Schweinsberg, F., Grossmann, T., Wendt-Gallitelli, M.F., and Meyermann, R. 1996. Demonstration of mercury in the human brain and other organs 17 years after metallic mercury exposure. Clin. Neuropathol. 15:139-144.
110. Ornitz, E.M. 1983. The functional neuroanatomy of infantile autism. Int. J. Neurosci. 19:85-124.
111. Palmeira, C.M., Moreno, A.J., and Madeira, V.M. 1995. Thiols metabolism is altered by the herbicides paraquat, dinoseb and 2,4-D: A study in isolated hepatocytes. Toxicol. Lett. 81:115-123.
112. Palmer, R.F., Blanchard, S., and Wood, R. 2009. Proximity to point sources of environmental mercury release as a predictor of autism prevalence. Health Place 15:18-24.
113. Paul, R., Augustyn, A., Klin, A., and Volkmar, F.R. 2005. Perception and production of prosody by speakers with autism spectrum disorder. J. Autism Dev. Disord. 35:205-220.
114. Peele, D.B., Farmer, J.D., and MacPhail, R.C. 1988. Behavioral consequences of chelator administration in acute cadmium toxicity. Fundam. Appl. Toxicol. 11:416-428.
115. Peng, J., Peng, L., Stevenson, F.F., Doctorow, W.R., and Anderson, J.K. 2007. Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson’s disease accelerate age-related neurodegeneration. J. Neurosci. 27:6914-6922.
116. Perry, E.K., Lee, M.L, Martin-Ruiz, C.M., Court, J.A., Volsen, S.G., Merrit, J., Folly, E., Iversen, P.E., Bauman, M.L., Perry, R.H., and Wenk, G.L. 2001. Cholinergic activity in autism: Abnormalities in the cerebral cortex and basal fore brain. Am. J. Psychiatry 158:1058-1066.
117. Peruzzo, B., Pastor, F.E., Blazquez, J.L., Schobitz, K., Pelaez, B., Amat, P., and Rodriguez, E.M. 2000. A second look at the barriers of the medial basal hypothalamus. Exp. Brain Res. 132:10-26.
118. Poling, J.S. 2008. Vaccines and autism revisited. N. Engl. J. Med. 359:655.
119. Porges, W.W., Doussard-Roosevelt, J.A., Portales, A.L., and Greenspan, S.I. 1996. Infant regulation of the vagal “brake” predicts child behavior problems: A psychobiological model of social behavior. Dev. Psychobiol. 8:697-712.
120. Rascher, K. and Mestres, P. 1980. Reaction of the hypothalamic ventricular lining following systemic administration of MSG. Scan Electron Microsc. 3:457-464.
121. Reiter, R.J., Guerrero, J.M., Garcia, J.J., and Acuna-Castroviejo, D. 1998. Reactive oxygen intermediate, molecular damage, and aging. Relation to melatonin. Ann. N.Y. Acad. Sci. 854:41-424.
122. Reiter, R.J., Tan, D.X., Mayo, J.C., Sainz, R.M., and Lopez-Burillo, S. 2002. Melatonin, longevity and health in the aged: An assessment. Free Radic. Res. 36:1323-1329.
123. Rimland, B. 1964. Infantile Autism, New York: Meredith Publishing Company.
124. Rimland, B. and McGinnis, W. 2002. Vaccines and autism. Lab. Med. 33:708-716.
125. Roda, E., Coccini, T., Acerbi, D., Castoldi, A., Bernocchi, G., and Manzo, L. 2008. Cerebellum cholinergic muscarinic receptor (subtype-2 and-3) and cytoarchitecture after developmental exposure to methylmercury: An immunohistological study in rat. J. Chem. Neuroanat. 35:285-294.
126. Rodier, P.M., Ingram, J.L., Tisdale, B., and Croog, V.J. 1997. Linking etiologies in humans and animal models: Studies of autism. Reprod. Toxicol. 11:417-422.
127. Saeed, R.W., Varma, S., Nemeroff, T.P., Sherry, B., Balakhaneh, D., Huston, J., Tracey, K.J., Al-Abed, Y., and Metz, C.N. 2005. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J. Exp. Med. 201:1113-1123.
128. Sajdel-Sulkowska, E.M., Lipinksi, B., Windom, H., Audhya, T., and McGinnis, W. 2008. Oxidative stress in autism: Elevated cerebellar 3-nitrotyrosine levels. Am. J. Biochem. Biotechnol. (Special Issue on Autism Spectrum Disorders) 4:73-84.
129. Santos, F.W., Zeni, G., Rocha, J.B., Weis, S.N., Fachinetto, J.M., Favero, A.M., and Noguiera, C.W. 2005. Diphenyl diselenide reverses cadmium-induced oxidative damage on mice tissues. Chem. Biol. Interact. 151:159-165.
130. Shaffer, M.J., Jackson, C.E., Szabo, C.A., and Simpson, C.B. 2005. Vagal nerve stimulation: Clinical and electrophysiological effects on vocal fold function. Ann. Otol. Rhinol. Laryngol. 114:7-14.
131. Singh, P., Mann, K.A., Mangat, H.K., and Kaur, G. 2003. Prolonged glutamate excitotoxicity: Effects on mitochondrial antioxidants and antioxidant enzymes. Mol. Cell. Biochem. 243:139-145.
132. Souza, V., Escobar Md Mdel, C., Gomez-Quiroz, L., Bucio, L., Hernandez, E., Cossio, E.C., and Gutierrez-Ruiz, M.C. 2004. Acute cadmium exposure enhances AP-1 DNA binding and induces cytokines expression and heat shock protein in HepG2 cells. Toxicology 197:213-228.
133. Spellman, S.J. and Warner, H.A. 1977. Parkinsonism and the gut. Prim. Care 4:447-462.
134. Suh, J.H., Walsh, W.J., McGinnis, W.R., Lewis, A., and Ames, B.N. 2008. Altered sulfur amino acid metabolism in immune cells of children diagnosed with autism. Am. J. Biochem. Biotechnol. (Special Issue on Autism Spectrum Disorders) 4:105-113.
135. Tanguay, P.E. and Edwards, R.M. 1982. Electrophysiological studies of autism: The whisper of the bang. J. Autism Dev. Disord. 12:177-184.
136. Terai, K., Munesue, T., and Hiratani, M. 1999. Excessive water drinking behavior in autism. Brain Dev. 21:103-106.
137. Thunberg, G., Ahlsen, E., and Sandberg, A.D. 2007. Children with autistic spectrum disorders and speech-generating devices: Communication in different activities at home. Clin. Linguist Phonology 21:457-479.
138. Tordjman, S., Anderson, G.M., Pichard, N., Charbuy, H., and Touitou, Y. 2005. Noctural excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. Biol. Psychiatry 57:134-138.
139. Torrente, F., Ashwood, R.D., Day, R., Machado, N., Furlano, R.I., Anthony, A., Davies, S.E., Wakefield, A.J., Thomson, M.A., Walker-Smith, J.A., and Murch, S.H. 2002. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol. Psychiatry 7:375-382.
140. Tuchman, R.F. and Rapin, I. 1997. Regression in pervasive developmental disorders: Seizures and epileptiform electroencephalogram correlates. Pediatrics 99:560-566.
141. Urena-Guerrero, M.E., Lopez-Perez, S.J., and Beas-Zarate, C. 2003. Neonatal monosodium glutamate treatment modifies glutamic acid decarboxylase activity during rat brain postnatal development. Neurochem. Int. 42:269-276.
142. Vahter, M., Mottet, N.K., Friberg, L., Lind, B., Shen, D.D., and Burbacher, T. 1994. Speciation of mercury in the primate blood and brain following long-term exposure to methyl mercury. Toxicol. Appl. Pharmacol. 124:221-229.
143. Vargas, D.L., Nascimbene, C., Krishnan, C., Zimmerman, A.W., and Pardo, C.A. 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57:67-81.
144. Vitkovic, L., Konsman, J.P., Bockaert, J., Dantzer, R., Homburger, V., and Jacque, C. 2000. Cytokine signals propagate through the brain. Mol. Pscyhiatry 5:604-615.
145. Wakefield, A.J., Murch, S.H., Anthony, A., Linnell, J., Casson, D.M., Malik, M., Berelowitz, W., Dhillon, A.P., Thomson, M.A., Harvey, P., Valentine, A., Davies, S.E., and Walker-Smith, J.A. 1998. Illeal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351:637-641.
146. Wakefield, A.J., Thomson, M.A., Walker-Smith, J.A., and Murch, S.H. 2002. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol. Psychiatry 7:375-382.
147. Walker, R. and Lupien, J.R. (2000). The safety evaluation of monosodium glutamate. J. Nutr. 130:1049S-10452S.
148. Wang, Y., Fang, J., Leonard, S.S., and Rao, K.M. 2004. Cadmium inhibits the electron transfer chain and induces reactive oxygen species. Free Radic. Biol. Med. 36:1434-1443.
149. Weidenheim, K.M., Goodman, L., Dickson, D.W., Gillberg, C., Rastam, M., and Rapin, I. 2001. Etiology and pathophysiology of autistic behavior: Clues from two cases with an unusual variant of neuroaxonal dystrophy. J. Child Neurol. 16:809-819.
150. Weissman, J.R., Kelly, R.I., Bauman, M.L., Cohen, B.H., Murray, K.F., Mitchell, R.L., Kern, R.L., and Natowicz, M.R. 2008. Mitochondrial disease in autism spectrum disorder patients: A cohort analysis. Public Library of Science (PloS ONE) 3:1-6.
151. Werner, E. and Dawson, G. 2005. Validation of the phenomenon of autistic regression using home videotapes. Arch. Gen. Psychiatry 62:889-895.
152. Windham, G.C., Zhang, L., Gunier, R., Croen, L.A., and Grether, J.K. 2006. Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco Bay area. Environ. Health Perspect. 114:1438-1444.
153. Wislocki, G.B. and Putnam, T.J. 1920. Note on the anatomy of the areae postremae. Anat. Rec. 19:281-287.
154. Wu, X.F., Block, M.L., Zhang, W., Qin, L., Wilson, B., Zhang, W.Q., Veronesi, B., and Hong, J.S. 2005. The role of microglia in paraquat-induced dopaminergic neurotoxicity. Antioxid. Redox Signal. 7:654-661.
155. Wyllie, W.G. and Stern, R.O. 1931. Pink disease: Its morbid anatomy, with a note on treatment. Arch. Dis. Child 6:137-156.
156. Yang, B., Goulet, M., Boismenu, R., and Ferguson, A.V. 2004. Secretin depolarizes nucleus tractus solitarius neurons through activation of a nonselective cationic conductance. Am. J. Physiol. Regul. Comp. Physiol. 286:927-934.
157. Yao, W., Walsh, W.J., McGinnis, W.R., and Pratico, D. 2006. Altered vascular phenotype in autism: Correlation with oxidative stress. Arch. Neurol. 63:1161-1164.
158. Yun, A.J., Bazar, K.A., and Lee, P.Y. 2004. Pineal attrition, loss of cognitive plasticity, and onset of puberty during the teen years: Is it a modern maladaptation exposed by evolutionary displacement? Med. Hypotheses 63:939-950.
159. Zimmerman, A.W., Jyonouchi, H., Comi, A.M., Connors, S.L., Milstien, S., Varsou, A., and Heyes, M.P. 2005. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr. Neurol. 33:195-201.